Low molecular weight extraction process
AssigneeVelvet Antler Research New Zealand Limited
InventorStephen Roy Haines
Life of this patent
Estimating the term…
Abstract
A process for isolating low molecular weight (“LMW”) peptides from tissue in situ comprising the steps: a) homogenizing the tissue; b) mixing the homogenized tissue with an organic solvent to form a fully-wetted slurry; c) standing or agitating the slurry to denature the proteins in situ within the tissue; d) removing the organic solvent from the tissue; e) mixing the organic solvent-treated tissue of step d) with a sufficient volume of water or an aqueous solution to extract the peptides; f) separating a liquid extract from the tissue residue of step e) to obtain an aqueous solution containing the low molecular weight peptide fraction removed from the tissue.
Claims16
A process for isolating native, low molecular weight (“LMW”) peptides, which have a molecular weight, wherein said molecular weight is less than or equivalent to 10 kDa from tissue in situ comprising:
- a) homogenizing the tissue;
- b) mixing the homogenized tissue with an organic solvent to form a fully-wetted slurry;
- c) standing or agitating the slurry to denature high molecular weight proteins proteins in situ within the homogenized tissue;
- d) removing and discarding the organic solvent from the homogenized tissue prior to undertaking step (e);
- e) mixing the organic solvent-treated homogenized tissue of step d) that comprises the in situ-denatured high molecular weight proteins and the low molecular weight (“LMW”) peptides, which have a molecular weight, wherein said molecular weight is less than or equivalent to 10 kDa with water or an aqueous, non-organic solution that consists essentially of water and aqueous salts and/or buffer solutions, and does not contain ethanol, to extract the low molecular weight (“LMW”) peptides, which have a molecular weight, wherein said molecular weight is less than or equivalent to 10 kDa;
- and
- f) separating a liquid extract from the homogenized tissue residue of step e) to obtain an aqueous solution containing the low molecular weight peptide fraction removed from the tissue.
Dependencies are inferred from the claim text.